They're because we can't know what we haven't studied
Unlike traditional treatments like PDE5 inhibitors (e.g., Viagra or Cialis), which primarily target blood flow, PT-141 acts directly on the central nervous system
Starting with GHK-Cu alone allows assessment of baseline response before adding complexity and cost
On the flip side, their effects can be more sustainable and holistic improving body composition, energy levels, and health markers without forcing your body into an artificially suppressed appetite long-term
It sounds almost too simple, but dehydration is one of the most overlooked variables in how a man feels on TRT, and it can quietly distort the very lab results
Key metabolic effects include: Enhanced lipolysis through activation of fat breakdown pathways independent of growth hormone receptors Suppressed lipogenesis reducing conversion of non-fat substrates into stored fat Increased fat oxidation and energy expenditure in multiple species models No adverse effects on insulin sensitivity or glucose metabolism, unlike full-length growth hormone Independence from IGF-1 Signaling A critical distinction of AOD-9604 is its lack of IGF-1 pathway activation: No measurable changes in serum IGF-1 levels in human clinical trials Absence of growth-promoting effects on tissues No impact on blood glucose regulation or insulin resistance Avoidance of typical growth hormone side effects including edema and tissue overgrowth Metabolic Pathway Modulation Research indicates AOD-9604 influences energy metabolism through multiple mechanisms: Increased whole-body fat oxidation rates in animal models Enhanced metabolic rate without stimulant-like effects Potential modulation of uncoupling proteins in adipose tissue Effects on lipid metabolism that persist beyond plasma clearance Critical Mechanistic Gap: Despite extensive research, the primary receptor target for AOD-9604 remains unidentified
